QIAGEN N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.65 USD | +1.39% |
|
+4.12% | -6.98% |
Chart calendar Qiagen N.V.
2ad01ddc5ebff1e80.cOMgt5G-Z39ozD65Gy76ndWKqfBnkPz1OVnLp1UGX_8.GI8T2MWGN1IJ4W7dWGuI5JDz0ZhRoKTBc2mg_hhAKKAE0W3Vwc8JPAulSQ~29207c427080d4daef30c2e7357952d1
Upcoming events on Qiagen N.V.
Past events on Qiagen N.V.
| 04/04/2024 | American Association for Cancer Research Meeting |
| 26/03/2024 13:00 | BNP Exane Healthcare Conference |
| 05/03/2024 19:10 | TD Cowen Health Care Conference |
| 27/02/2024 08:00 | UBS European Healthcare Conference |
| 26/02/2024 08:00 | Morgan Stanley European MedTech and Life Sciences Conference |
| 07/02/2024 14:00 | Q4 2023 Earnings Call |
| 06/02/2024 21:05 | Q4 2023 Earnings Release |
| 29/01/2024 | Reverse Split: 24.25 of 25 |
| 29/01/2024 | Capital return instalment |
| 15/01/2024 15:00 | German Corporate Conference |
| 12/01/2024 08:00 | ODDO BHF Forum |
| 09/01/2024 14:00 | Commerzbank and ODDO BHF German Investment Conference |
| 08/01/2024 21:30 | JPMorgan Healthcare Conference |
| 11/12/2023 | Virtual DILS CEO Exane Conference |
| 28/11/2023 17:30 | Evercore ISI Healthcare Conference |
| 21/11/2023 | Kepler Cheuvreux Digital Diagnostics Day |
| 31/10/2023 13:00 | Q3 2023 Earnings Call |
| 30/10/2023 20:05 | Q3 2023 Earnings Release |
| 19/09/2023 15:00 | Berenberg & Goldman Sachs German Corporate Conference |
| 13/09/2023 19:00 | Baird Healthcare Conference |
Past dividends on Qiagen N.V.
| 29/01/2024 | 1.28 USD |
| 24/01/2017 | 1.04 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 526 1 526 0.06% | 1 870 1 858 0.68% | 2 252 2 198 2.44% | 2 142 2 139 0.12% | 1 965 1 960 0.26% | 2 010 |
|
EBITDA Million USD | Released Forecast Spread | 552 532 3.7% | 748 723 3.4% | 884 870 1.67% | 790 791 -0.14% | 659 675 -2.34% | 710 |
|
EBIT Million USD | Released Forecast Spread | 422 412 2.5% | 627 623 0.57% | 755 714 5.73% | 656 654 0.33% | 529 524 0.88% | 566 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -77,8 -77,9 0.13% | 439 364 20.66% | 626 564 11.04% | 513 538 -4.72% | 430 437 -1.7% | 498 |
|
Net income Million USD | Released Forecast Spread | -41,5 -29,5 -40.57% | 359 294 22.31% | 513 475 7.83% | 423 424 -0.14% | 341 344 -0.65% | 398 |
|
EPS USD | Released Forecast Spread | -0,19 -0,11 -62.85% | 1,58 1,30 20.88% | 2,28 2,17 4.8% | 1,90 1,96 -2.99% | 1,48 1,54 -3.96% | 1,77 |
| Announcement Date | 04/02/20 | 09/02/21 | 08/02/22 | 10/02/23 | 06/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 582 533 9.18% | 628 591 6.36% | 516 500 3.15% | 500 482 3.71% | 498 486 2.55% | 485 479 1.41% | 495 493 0.38% | 476 471 1.07% | 509 504 1.01% | 457 | 501 | 506 | 540 | 489 |
|
EBITDA Million USD | Released Forecast Spread | 232 207 12.1% | 266 240 11.11% | 179 165 8.14% | 176 158 11.2% | 169 164 2.57% | 158 163 -3.31% | 168 194 -13.27% | 158 149 5.95% | 175 175 -0.02% | 150 | 174 | 178 | 198 | 168 |
|
EBIT Million USD | Released Forecast Spread | 199 171 16.22% | 232 205 13.24% | 146 133 10.33% | 144 129 11.06% | 135 128 5.61% | 124 123 0.65% | 136 134 1.4% | 126 127 -0.37% | 142 139 2.34% | 117 | 139 | 143 | 161 | 127 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 95,7 94,5 1.29% | |||||||||||||
|
Net income Million USD | Released Forecast Spread | 129 115 12.64% | 155 138 12.44% | 96,7 78,2 23.67% | 82,4 78,1 5.44% | 88,8 73,7 20.58% | 85,0 75,1 13.24% | 80,8 86,1 -6.2% | 77,8 84,7 -8.14% | 97,7 92,3 5.76% | 76,3 | 95,9 | 100 | 114 | 84,0 |
|
EPS USD | Released Forecast Spread | 0,58 0,51 12.18% | 0,69 0,62 12.09% | 0,43 0,36 21.29% | 0,37 0,35 6.42% | 0,40 | 0,38 0,33 14.04% | 0,36 0,37 -2.98% | 0,35 0,38 -8.76% | 0,42 0,41 3.43% | 0,34 | 0,43 | 0,45 | 0,51 | 0,38 |
| Announcement Date | 08/02/22 | 27/04/22 | 26/07/22 | 07/11/22 | 10/02/23 | 03/05/23 | 08/08/23 | 30/10/23 | 06/02/24 | - | - | - | - | - |
More events
Past sector events for Qiagen N.V.
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 06:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 25/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 25/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 12:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 07:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- QGEN Stock
- Calendar Qiagen N.V.
